AGDD 2025 | D2S05 - Workshop Closing Remarks
U.S. Food and Drug Administration (Office of Generic Drugs) · June 11, 2026
Dr. Lei Jung, deputy director in the FDA Office of Generic Drugs, delivered closing remarks at the two-day "Advancing Generic Drug Development: Translating Science to Approval" workshop, highlighting research priorities under GDUFA, advances in modeling and bioequivalence science, and announcing two follow-up workshops in October and November with virtual participation available.
AI-Generated Content: All content on this page was generated by AI to highlight key points from the meeting. For complete details and context, we recommend watching the full video. so we can fix them.
No transcript available.
No outline available for this source.
No related articles available for this source.
No highlights available for this source.
No claims available for this source.
No actions available for this source.
No topics available for this source.
No clarifying details available for this source.
No discussions available for this source.
No community relevance data available for this source.
No funding sources available for this source.
No speakers available for this source.
No transcript available for this source.